Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer

NCT00553410 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4884

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Letrozole
DRUG: Letrozole

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]